Tag: life sciences
-
NIH Nixes Convalescent Plasma Covid-19 Therapy
An expert panel convened by National Institutes of Health says current data do not support recommending convalescent plasma as a treatment for Covid-19 infections.
-
Late-Stage Covid-19 Vaccine Trial Underway in U.S.
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes.
-
Food Allergy Biotech Acquired for $2.6B
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion.
-
Covid-19 Vaccines, Therapies – 31 August 2020
The European Commission announced today a contribution of €400 million ($US 477 million) to the COVID-19 Vaccine Global Access, or Covax, consortium.
-
Engineered Mosquitoes Approved for Disease Control
In an apparent end to a long-running dispute, authorities in the Florida Keys approved a field trial of engineered mosquitoes to control tropical diseases.
-
DoD Funding Variable Covid-19 Vaccine Technology
The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus.
-
Vaccine Blocks Covid-19 Infections in Animal Tests
An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways.
-
Biotechs, Univ. Labs Partner on Covid-19 Combo Therapy
Two biotechnology companies are developing a Covid-19 treatment that combines engineered antibodies and natural killer immune system cells.
-
Phone Camera, A.I. Detect Early Diabetes
Researchers devised techniques with a smartphone app, and data analyzed with artificial intelligence, to identify people in early stages of type 2 diabetes.
-
Sanofi Acquires Immune Disease Biotech in $3.7B Deal
A developer of small-molecule therapies for autoimmune diseases, including multiple sclerosis, and other immune disorders is being acquired by Sanofi.